Xiaowei Xu

549 citations
15 papers · 374 indexed · h-index 13
    • Microtubule and mitosis dynamics 4
    • Genomics and Chromatin Dynamics 7
    • Epigenetics and DNA Methylation 6
    • DNA Repair Mechanisms 4
    • CRISPR and Genetic Engineering 3
    • Pluripotent Stem Cells Research 2
    • Hedgehog Signaling Pathway Studies 2
    • Cancer-related Molecular Pathways 3

Xiaowei Xu

15 papers receiving 373 citations

Peers

Xiaowei Xu
Comparison fields: 5 of 62
  • Cell Biology 80
  • Molecular Biology 316
  • Aging 6
  • Genetics 65
  • Oncology 40
Replace Lee Finlan with:
Lee Finlan United Kingdom
Odile Chevallier France
Anne‐Sophie Macé France
Amaal Abrahams South Africa
Nathalie Ly France
Chuen Yan Leung United Kingdom
Letícia Koch Lerner Brazil
Heather A. Wallace United States
Rosa Ventrella United States
Grigorios Koulouras United Kingdom
Xiaowei Xu relative to Lee Finlan United Kingdom Lee Finlan's profile →
Citations per field
00.5×6.2×
Lee Finlan · 1×
Citations per year

Countries citing papers authored by Xiaowei Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Xu more than expected).

Fields of papers citing papers by Xiaowei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Xu. The network helps show where Xiaowei Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaowei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaowei Xu Line = papers co-authored together Xiaowei Xu links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 202328
2 202215
3 20224
4 202221
5 202113
6 202071
7 201928
8 201830
9 201726
10 201731
11 201726
12 201616
13 201521
14 201135
15 20099

About Xiaowei Xu

Xiaowei Xu is a scholar working on Cell Biology, Molecular Biology and Ophthalmology, having authored 15 papers that have together received 374 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (7 papers), Epigenetics and DNA Methylation (6 papers), DNA Repair Mechanisms (4 papers), Microtubule and mitosis dynamics (4 papers), CRISPR and Genetic Engineering (3 papers), Cancer-related Molecular Pathways (3 papers), Pluripotent Stem Cells Research (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). The work is most often cited by research in Cell Biology (80 citations), Molecular Biology (316 citations) and Aging (6 citations). Xiaowei Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhiguo Zhang, Xu Hua, Zhiming Li, Chuanmao Zhang, Qing Jiang, Boyan Zhang, Gang Wang, Hui Zhou, Albert Serra‐Cardona and Chun-Long Chen. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026